Companion Diagnostics for Cancer: A Market Study on Breast, Lung, and Colorectal Cancers
As the Companion Diagnostics Market expands, ethical concerns are becoming more prominent. Issues include patient privacy, informed consent, and equitable access to testing. Genetic information obtained through companion diagnostics must be protected to prevent misuse. Additionally, healthcare providers must ensure that patients fully understand the implications of diagnostic results before consenting to treatment. Addressing these ethical challenges is essential for maintaining public trust.
4 Views